SEQUENT Income Statement - TTM - Sequent Scientific Limited

Income Statement (TTM)

Sequent Scientific Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	12,735	13,153	13,616	13,869	13,880	13,909	14,128	14,336	14,207	14,380	14,209	14,128	14,212	13,705	13,697	14,267	14,494	15,109	15,514	16,026
Change (%)		3.28	3.52	1.85	0.08	0.21	1.57	1.47	-0.90	1.22	-1.19	-0.57	0.59	-3.56	-0.06	4.16	1.59	4.24	2.68	3.30
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	6,689	6,856	7,165	7,107	7,515	7,818	8,149	8,234	8,428	8,527	8,581	8,562	8,481	8,113	7,853	7,792	8,103	8,321	8,375	8,578
Change (%)		2.49	4.51	-0.82	5.74	4.04	4.23	1.05	2.35	1.18	0.64	-0.22	-0.95	-4.34	-3.21	-0.77	3.98	2.70	0.64	2.42
% of Revenue	52.53	52.12	52.62	51.24	54.14	56.21	57.68	57.44	59.32	59.30	60.39	60.60	59.68	59.20	57.33	54.62	55.90	55.08	53.98	53.52

Gross Operating Profit	6,046	6,297	6,451	6,762	6,365	6,091	5,979	6,102	5,779	5,853	5,628	5,566	5,731	5,592	5,845	6,475	6,392	6,787	7,139	7,448
Change (%)		4.16	2.44	4.82	-5.87	-4.30	-1.83	2.05	-5.29	1.27	-3.84	-1.10	2.96	-2.41	4.51	10.78	-1.29	6.19	5.18	4.34
% of Revenue	47.47	47.88	47.38	48.76	45.86	43.79	42.32	42.56	40.68	40.70	39.61	39.40	40.32	40.80	42.67	45.38	44.10	44.92	46.02	46.48

SG&A	1,751	1,782	1,913	2,087	2,317	2,322	2,337	2,302	2,327	2,533	2,620	2,616	2,655	2,565	2,549	2,485	2,534	2,708	2,898	3,068
Change (%)		1.74	7.37	9.11	11.03	0.18	0.66	-1.49	1.09	8.85	3.41	-0.12	1.49	-3.40	-0.64	-2.52	2.01	6.85	7.00	5.87
% of Revenue	13.75	13.55	14.05	15.05	16.70	16.69	16.54	16.06	16.38	17.62	18.44	18.52	18.69	18.72	18.61	17.41	17.49	17.92	18.68	19.14

R&D
Change (%)
% of Revenue

OpEx	11,184	11,424	11,929	12,503	12,831	13,156	13,549	13,893	13,913	14,314	14,363	14,401	14,390	13,862	13,465	13,728	13,627	14,146	14,506	14,950
Change (%)		2.15	4.42	4.81	2.62	2.54	2.98	2.54	0.14	2.89	0.34	0.27	-0.07	-3.68	-2.86	1.96	-0.74	3.81	2.55	3.06
% of Revenue	87.81	86.85	87.61	90.15	92.44	94.58	95.90	96.91	97.93	99.55	101.08	101.93	101.26	101.14	98.30	96.22	94.02	93.63	93.51	93.29

Operating Income	1,552	1,730	1,688	1,366	1,049	753	580	443	294	65	-153	-273	-179	-156	233	539	867	963	1,007	1,076
Change (%)		11.46	-2.44	-19.05	-23.23	-28.18	-23.05	-23.57	-33.66	-77.87	-335.91	77.84	-34.45	-12.76	-249.12	131.69	60.87	11.01	4.62	6.82
% of Revenue	12.19	13.15	12.39	9.85	7.56	5.42	4.10	3.09	2.07	0.45	-1.08	-1.93	-1.26	-1.14	1.70	3.78	5.98	6.37	6.49	6.71

Interest Expense	-309	-275	-193	-198	-105	-78	-135	-196	-221	-284	-297	-334	-379	-407	-464	-540	-540	-564	-560	-537
Change (%)		-11.00	-30.05	2.63	-46.69	-26.11	73.55	44.73	13.26	28.34	4.57	12.39	13.35	7.54	14.01	16.29	0.09	4.39	-0.79	-3.97
% of Revenue	-2.43	-2.09	-1.41	-1.42	-0.76	-0.56	-0.96	-1.36	-1.56	-1.98	-2.09	-2.36	-2.66	-2.97	-3.39	-3.78	-3.73	-3.73	-3.61	-3.35

Net Income	793	963	954	805	713	529	410	263	74	-186	-1,212	-1,410	-1,457	-1,285	-359	55	165	117	219	297
Change (%)		21.33	-0.85	-15.64	-11.42	-25.80	-22.61	-35.72	-72.04	-352.96	550.59	16.41	3.28	-11.76	-72.09	-115.31	200.15	-29.31	87.78	35.65
% of Revenue	6.23	7.32	7.01	5.81	5.14	3.80	2.90	1.84	0.52	-1.30	-8.53	-9.98	-10.25	-9.38	-2.62	0.38	1.14	0.77	1.41	1.85

Source: Capital IQ

Sequent Scientific Limited - Income Statement (TTM)

Income Statement (TTM)

Other Listings